Skip to main content
logo
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.45
-0.40 (-2.52%)
At close: Aug 10, 2026, 4:00 PM EDT
15.50
+0.05 (0.32%)
After-hours: Aug 10, 2026, 6:35 PM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,0562,1111,2651,2936153,238
Market Cap Growth
34.51%66.83%-2.16%110.39%-81.02%84.78%
Enterprise Value
1,6771,787986.021,040233.32,781
Last Close Price
15.4515.958.988.994.3222.87
PE Ratio
6.717.71224.50---
Forward PE
19.8119.6924.06---
PS Ratio
6.617.465.387.374.5971.01
PB Ratio
3.433.633.353.421.526.76
P/TBV Ratio
4.903.833.523.451.546.29
P/FCF Ratio
11.7615.5928.68---
P/OCF Ratio
11.7515.5628.50---
EV/Sales Ratio
5.396.314.195.931.7460.98
EV/EBITDA Ratio
10.9414.3766.81---
EV/EBIT Ratio
12.2617.04----
EV/FCF Ratio
9.5913.2022.36---
Debt / Equity Ratio
0.070.100.170.220.020.02
Debt / EBITDA Ratio
0.290.605.38---
Debt / FCF Ratio
0.300.551.80---
Net Debt / Equity Ratio
-0.62-0.56-0.74-0.67-0.94-0.95
Net Debt / EBITDA Ratio
-1.74-2.60-18.913.163.512.57
Net Debt / FCF Ratio
-1.78-2.39-6.337.404.782.90
Asset Turnover
0.440.430.430.340.260.09
Inventory Turnover
0.730.770.720.440.260.07
Quick Ratio
4.854.694.044.858.7411.85
Current Ratio
5.425.254.575.509.6012.63
Return on Equity (ROE)
59.76%59.91%1.52%-19.92%-24.46%-40.81%
Return on Assets (ROA)
43.47%40.54%-0.66%-18.13%-22.36%-36.05%
Return on Invested Capital (ROIC)
134.39%148.07%-3.24%-123.78%-494.22%-917.12%
Return on Capital Employed (ROCE)
23.93%18.89%-1.01%-20.48%-24.04%-38.69%
Earnings Yield
15.26%12.98%0.45%---
FCF Yield
8.51%6.42%3.49%---
Buyback Yield / Dilution
5.66%5.13%-2.07%-0.93%-9.70%-9.20%
Total Shareholder Return
5.66%5.13%-2.07%-0.93%-9.70%-9.20%
SEC Filings: 10-K · 10-Q